Discontinuation of therapy among COPD patients who experience an improvement in exacerbation status.

The extensive use of ICS and the relatively high persistence to ICS-containing regimens in individuals who had a decrease in exacerbation occurrence highlight a need for the development and implementation of de-escalation strategies in clinical practice.